4
Changes in Ownership
Definium Therapeutics, Inc. Filed Acc 0001193125-26-126830
Chief Medical Officer sold 8,018 shares at $18.47 ($148,092)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Karlin Daniel Chief Medical Officer | 2026-03-25 | Sale 10b5-1 | −8,018 | $18.47 | $148,092 | 413,317 | D |
| Open-market sales · 8,018 sh · avg $18.47 · $148,092 | |||||||
Loading xslF345X06/ownership.xml…